• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

48
12
12
10
8

COUNTRY

7
6
4
2
2

CATEGORIES

  • 47
  • 23
  • 16
  • 12
  • 12
  • 9
  • 8
  • 7
  • 5
  • 4
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

42
48
63
147

PUBLISHED

4
17
46
147

PRODUCT TYPE

106
40
1

Search "AstraZeneca: Performance, Products, Pipeline and Potential" returned 147 results.

PRODUCT TITLE

AstraZeneca PLC (AZN) - Financial and Strategic SWOT Analysis Review

AstraZeneca PLC (AZN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData...

April 2014
FROM

BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges

BioPharmaceutical Industry in China - An In Depth Analysis of Multinational and Chinese Biopharma Companies, Industry Trends, Environment, Regulation, Market Drivers, Restraints, Opportunities & Challenges”...

May 2013
FROM

AstraZeneca PLC Market Share Analysis

AstraZeneca PLC Market Share Analysis Summary GlobalData’s new report, “AstraZeneca PLC Market Share Analysis” provides in-depth information on AstraZeneca PLC ’s market position in the metered dose...

June 2011
FROM

Diabetes - KOL Insight and Consensus Outlook Modules

The medium term: battle lines are drawn The fundamental drivers of the global diabetes market are strong and continue to fuel growth Rising levels of obesity and disease prevalence in both established...

September 2013
FROM
The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016 The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016 - Product Thumbnail Image

The Asthma, COPD & Allergic Rhinitis Market Outlook to 2016

The report provides an in-depth analysis of the respiratory franchise It also highlights the key R&D trends that may influence treatment sales and includes a thorough analysis of the competitive dynamics...

May 2011
FROM
The Cancer Market Outlook to 2016 The Cancer Market Outlook to 2016 - Product Thumbnail Image

The Cancer Market Outlook to 2016

The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector This report presents leading...

June 2011
FROM
Lung Cancer Therapeutics Market Outlook and Pipeline Analysis Lung Cancer Therapeutics Market Outlook and Pipeline Analysis - Product Thumbnail Image

Lung Cancer Therapeutics Market Outlook and Pipeline Analysis

With over 50% of all non-small cell lung cancer (NSCLC) patients diagnosed at the advanced stages of the disease, and 95% of all small-cell lung cancer (SCLC) patients unsuitable for surgical resection,...

November 2009
FROM
Global Biopharma Outlook 2012 - Major US and EU Pharma Global Biopharma Outlook 2012 - Major US and EU Pharma - Product Thumbnail Image

Global Biopharma Outlook 2012 - Major US and EU Pharma

Global Biopharma Outlook 2012 –Major US and EU Pharma Unarguably 2011 was one of the very good years for the global Pharma industry as the USFDA approved a trend setting 39 new drugs, which is way ahead...

January 2012
FROM
DPP IV Inhibitors - Global Strategic Business Report DPP IV Inhibitors - Global Strategic Business Report - Product Thumbnail Image

DPP IV Inhibitors - Global Strategic Business Report

This report analyzes the worldwide markets for DPP-IV Inhibitors in US$ Million by the following drugs – Sitagliptin, Vildagliptin, Saxagliptin, and Other DPP-IV Inhibitors (including Linagliptin and...

September 2011
FROM

Chronic Obstructive Pulmonary Disease (COPD) Market to 2019 - Highly-Priced New Combination Products Forecast to Capture Significant Market Share and Drive Growth

The global COPD market is estimated to currently be worth $11 3 billion, and is forecast to reach a value of $15 6 billion by 2019 Much of this growth will be fuelled by a high number of new, more efficacious...

June 2013
FROM
Global Biopharma Outlook 2011: Major US and EU Global Biopharma Outlook 2011: Major US and EU - Product Thumbnail Image

Global Biopharma Outlook 2011: Major US and EU

The year 2011 and 2012 will be a bonanza for generic companies, as large innovator companies will lose patent exclusivity on prescription drugs worth over $70b in sales It is imperative to understand...

February 2011
FROM

Obesity Therapeutics to 2019 - Safety Concerns Hinder Drug Performance Despite Large Market Opportunity

Obesity is often described as a global endemic, with incidence dramatically increasing over the past decades, particularly in developed countries Being overweight or obese is a major risk factor in...

August 2013
FROM

ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of Treatment

GBI Research, the leading business intelligence provider, has released its latest research “ADHD Therapeutics Market to 2018 - New Diagnostic Parameters for Adult ADHD Offer Hope for Higher Rates of...

April 2013
FROM
Astra Tech AB - Strategic SWOT Analysis Review Astra Tech AB - Strategic SWOT Analysis Review - Product Thumbnail Image

Astra Tech AB - Strategic SWOT Analysis Review

Astra Tech AB - Strategic SWOT Analysis Review Summary Astra Tech AB (Astra Tech) is a medical device company engaged in the research, development, manufacture and marketing of dental implants and...

August 2011
FROM
Small Molecule Kinase Inhibitors - Global Strategic Business Report Small Molecule Kinase Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Small Molecule Kinase Inhibitors - Global Strategic Business Report

This report analyzes the Global Market for Small Molecule Kinase Inhibitors in Millions of US$ by the following Product Segments: Gleevec/Glivec, Tarceva, Sutent, Nexavar, Sprycel, Iressa, Tykerb/Tyverb,...

July 2009
FROM

Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Bile Duct Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Bile Duct Cancer Therapeutics -...

January 2012
FROM
The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights - Product Thumbnail Image

The Global Pain Therapeutics Market, 4th Edition: Market Trends & R&D Insights

Pain continues to present numerous challenges to the biopharmaceutical industry According to the American Academy of Pain Medicine, over 76 million Americans suffer from pain Indeed, pain affects more...

October 2010
FROM

Diabetes: Battle for Ascendancy Escalates in Expanding Market – KOL Insight

Diabetes is one of the few disease areas that has retained its market value despite the entry of generics, the rise in drug prices and prevalence of the disease has allowed drug sales to soar to a worldwide...

August 2013
FROM

Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018

Gallbladder Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Summary GlobalData, the industry analysis specialist, has released its new report, “Gallbladder Cancer Therapeutics...

January 2012
FROM
The CNS Market Outlook to 2010 The CNS Market Outlook to 2010 - Product Thumbnail Image

The CNS Market Outlook to 2010

Maximize future market opportunity with the help of this NEW report... The traditional markets of depression and schizophrenia will see further product launches in the next few years, however many...

October 2005
FROM
Loading Indicator